文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

脓毒症与肥胖悖论:体型的影响不止一面

Sepsis and the Obesity Paradox: Size Matters in More Than One Way.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论在脓毒症住院患者中,肥胖与院内死亡降低相关,但乳酸>5 mmol/L时该获益消失;以APACHE III校正后肥胖悖论不再出现。

该研究回顾性分析美国内布拉斯加州奥马哈5家社区医院和1家学术医疗中心共7967例成人脓毒症住院患者,按体重指数分为低体重、正常体重、超重和肥胖组,采用多变量logistic回归评估院内死亡的比值比,并检验体重指数与各协变量的交互作用。总体未校正死亡率为12.1%,体重指数越高死亡率越低(所有比较P<0.007)。校正后的肥胖死亡获益在乳酸较高患者中变小,乳酸>5 mmol/L时高体重指数组未见死亡获益;低平均动脉压与高死亡的关联在各体重指数组间恒定。以APACHE III评分作为协变量后未观察到肥胖悖论。

要点

  • 7967例成人脓毒症住院患者总体未校正院内死亡率为12.1%,体重指数越高死亡率越低(所有比较P<0.007)。
  • 校正后肥胖的死亡获益在乳酸较高患者中变小,乳酸>5 mmol/L时高体重指数组未见死亡获益。
  • 低平均动脉压与高死亡的关联在各体重指数组间恒定。
  • 以APACHE III评分作为协变量后未观察到肥胖悖论。
  • ICU队列中观察到相似结果。

适用人群与场景

  • 美国内布拉斯加州奥马哈5家社区医院和1家学术医疗中心收治的7967例成人脓毒症住院患者。
  • 亚组分析使用ICU队列。

研究设计与关键结果

  • 研究类型:对前瞻性收集临床数据的回顾性分析;样本量7967例成人脓毒症住院患者;设置:美国内布拉斯加州奥马哈5家社区医院和1家学术医疗中心。
  • 按体重指数分为低体重、正常体重、超重、肥胖组;采用多变量logistic回归估计院内死亡比值比,并评估体重指数与各协变量的双向交互作用。
  • 总体未校正死亡率为12.1%,体重指数越高死亡率越低(所有比较P<0.007)。
  • 校正后的肥胖死亡获益在乳酸较高患者中变小,乳酸>5 mmol/L时高体重指数组未见死亡获益。
  • 低平均动脉压与高死亡的关联在各体重指数组间恒定。
  • ICU队列中观察到相似结果;以APACHE III评分作为协变量后未观察到肥胖悖论。

证据类型、等级与局限

  • 证据类型:对前瞻性收集临床数据的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,体重指数是脓毒症患者院内死亡的预测因素,为肥胖悖论提供进一步证据;作者指出疾病严重程度至关重要,无论以较高乳酸还是APACHE III评分量化。
  • 作者认为,肥胖悖论并非单纯的体重指数与死亡关联,并强调疾病严重程度的重要性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Multiple studies have demonstrated an obesity paradox such that obese ICU patients have lower mortality and better outcomes. We conducted this study to determine if the mortality benefit conferred by obesity is affected by baseline serum lactate and mean arterial pressure.

DESIGN: Retrospective analysis of prospectively collected clinical data.

SETTING: Five community-based and one academic medical center in the Omaha, NE.

PATIENTS: 7,967 adults hospitalized with sepsis.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Patients were categorized by body mass index as underweight, normal weight, overweight, or obese. Multivariable logistic regression models were used to estimate the odds of in-hospital death by body mass index category; two-way interactions between body mass index and each covariate were also evaluated. Subgroup and sensitivity analyses were conducted using an ICU cohort and Acute Physiology and Chronic Health Evaluation III scores, respectively. The overall unadjusted mortality rate was 12.1% and was consistently lower in higher body mass index categories (all comparisons, p < 0.007). The adjusted mortality benefit observed in patients with higher body mass index was smaller in patients with higher lactate levels with no mortality benefit in higher body mass index categories observed at lactate greater than 5 mmol/L. By contrast, the association between lower MAP and higher mortality was constant across body mass index categories. Similar results were observed in the ICU cohort. Finally, the obesity paradox was not observed after including Acute Physiology and Chronic Health Evaluation III scores as a covariate.

CONCLUSIONS: Our retrospective analysis suggests that although patient size (i.e., body mass index) is a predictor of in-hospital death among all-comers with sepsis-providing further evidence to the obesity paradox-it adds that illness severity is critically important whether quantified as higher lactate or by Acute Physiology and Chronic Health Evaluation III score. Our results highlight that the obesity paradox is more than a simple association between body mass index and mortality and reinforces the importance of illness severity.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Jagan N, Morrow LE, Walters RW, et al. Sepsis and the Obesity Paradox: Size Matters in More Than One Way. Crit Care Med. 2020. PMID: 32590388. doi:10.1097/CCM.0000000000004459

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。